Checkpoint Therapeutics Inc [NASDAQ: CKPT] price plunged by -0.12 percent to reach at -$0.01.
The one-year CKPT stock forecast points to a potential upside of 3.7. The average equity rating for CKPT stock is currently 2.33, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Checkpoint Therapeutics Inc [CKPT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CKPT shares is $4.33 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CKPT stock is a recommendation set at 2.33. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
D. Boral Capital have made an estimate for Checkpoint Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 13, 2025. While these analysts kept the previous recommendation, B. Riley Securities raised their target price to Buy. The new note on the price target was released on July 14, 2022, representing the official price target for Checkpoint Therapeutics Inc stock. Previously, the target price had yet another raise to $18, while B. Riley Securities analysts kept a Buy rating on CKPT stock.
The Average True Range (ATR) for Checkpoint Therapeutics Inc is set at 0.03, with the Price to Sales ratio for CKPT stock in the period of the last 12 months amounting to 9071.87. The Price to Book ratio for the last quarter was 21.44, with the Price to Cash per share for the same quarter was set at 0.38.
CKPT Stock Performance Analysis:
Checkpoint Therapeutics Inc [CKPT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.48. With this latest performance, CKPT shares gained by 3.22% in over the last four-week period, additionally plugging by 26.36% over the last 6 months – not to mention a rise of 105.42% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CKPT stock in for the last two-week period is set at 69.05, with the RSI for the last a single of trading hit 71.51, and the three-weeks RSI is set at 64.95 for Checkpoint Therapeutics Inc [CKPT]. The present Moving Average for the last 50 days of trading for this stock 4.07, while it was recorded at 4.16 for the last single week of trading, and 3.28 for the last 200 days.
Insight into Checkpoint Therapeutics Inc Fundamentals:
Checkpoint Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.91 and a Current Ratio set at 1.91.
Checkpoint Therapeutics Inc [CKPT] Institutonal Ownership Details
The top three institutional holders of CKPT stocks are: ARMISTICE CAPITAL, LLC with ownership of 2.51 million shares, which is approximately 6.8608%. VANGUARD GROUP INC, holding 1.34 million shares of the stock with an approximate value of $$2.87 million in CKPT stocks shares; and VANGUARD GROUP INC, currently with $$0.65 million in CKPT stock with ownership which is approximately 0.8292%.
